Abstract
The sharing of legacy preclinical safety data among pharmaceutical companies and its integration with other information sources offers unprecedented opportunities to improve the early assessment of drug safety. Here, we discuss the experience of the eTOX project, which was established through the Innovative Medicines Initiative to explore this possibility.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Obiol-Pardo, C. et al. A multiscale simulation system for the prediction of drug-induced cardiotoxicity. J. Chem. Inf. Model. 51, 483–492 (2011).
Carbonell, P. et al. Hepatotoxicity prediction by systems biology modeling of disturbed metabolic pathways using gene expression data. ALTEX 34, 219–234 (2017)10.14573/altex.1602071.
Harvey, J. et al. Management of organic impurities in small molecule medicinal products: deriving safe limits for use in early development. Regul. Toxicol. Pharmacol. 84, 116–123 (2017)10.1016/j.yrtph.2016.12.011.
Carrió, P. et al. Applicability Domain Analysis (ADAN): a robust method for assessing the reliability of drug property predictions. J. Chem. Inf. Model. 54, 1500–1511 (2014).
Hewitt, M. et al. Ensuring confidence in predictions: a scheme to assess the scientific validity of in silico models. Adv. Drug Deliv. Rev. 86, 101–111 (2015)10.1016/j.addr.2015.03.005.
Author information
Authors and Affiliations
Consortia
Corresponding authors
Ethics declarations
Competing interests
Some of the authors are employed in the pharmaceutical industry or in small and medium-sized enterprises, as indicated in the author affliations.
Supplementary information
Supplementary information S1 (box)
eTOX-related web sites and publications (PDF 173 kb)
Rights and permissions
About this article
Cite this article
Sanz, F., Pognan, F., Steger-Hartmann, T. et al. Legacy data sharing to improve drug safety assessment: the eTOX project. Nat Rev Drug Discov 16, 811–812 (2017). https://doi.org/10.1038/nrd.2017.177
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.177
This article is cited by
-
CSL-Tox: an open-source analytical framework for the comparison of short-term and long-term toxicity end points and assessing the need of chronic studies in drug development
Scientific Reports (2023)
-
Flame: an open source framework for model development, hosting, and usage in production environments
Journal of Cheminformatics (2021)
-
An open source chemical structure curation pipeline using RDKit
Journal of Cheminformatics (2020)
-
BRADSHAW: a system for automated molecular design
Journal of Computer-Aided Molecular Design (2020)
-
The European Innovative Medicines Initiative: Progress to Date
Pharmaceutical Medicine (2018)